€
1.40
Jun 21
Business Description
Shanghai Pharmaceuticals Holding Co Ltd
NAICS : 446110
ISIN : CNE1000012B3
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 5.7 | |||||
Interest Coverage | 5.75 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.09 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year EBITDA Growth Rate | -7 | |||||
3-Year EPS without NRI Growth Rate | -10.2 | |||||
3-Year FCF Growth Rate | -23.1 | |||||
3-Year Book Growth Rate | 5.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.76 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.1 | |||||
9-Day RSI | 49.65 | |||||
14-Day RSI | 50.86 | |||||
6-1 Month Momentum % | 12.8 | |||||
12-1 Month Momentum % | -18.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.34 | |||||
Quick Ratio | 1.07 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 53.4 | |||||
Days Sales Outstanding | 105.72 | |||||
Days Payable | 87.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.6 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 11.5 | |||||
Forward Dividend Yield % | 5.6 | |||||
5-Year Yield-on-Cost % | 8.04 | |||||
3-Year Average Share Buyback Ratio | -9.2 | |||||
Shareholder Yield % | -7.15 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 11.63 | |||||
Operating Margin % | 3.58 | |||||
Net Margin % | 1.44 | |||||
FCF Margin % | -0.27 | |||||
ROE % | 5.53 | |||||
ROA % | 1.79 | |||||
ROIC % | 7.08 | |||||
ROC (Joel Greenblatt) % | 17.11 | |||||
ROCE % | 9.51 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.47 | |||||
Forward PE Ratio | 14.82 | |||||
PE Ratio without NRI | 15.84 | |||||
Shiller PE Ratio | 13.17 | |||||
Price-to-Owner-Earnings | 56.78 | |||||
PEG Ratio | 4.06 | |||||
PS Ratio | 0.27 | |||||
PB Ratio | 1.01 | |||||
Price-to-Tangible-Book | 1.35 | |||||
Price-to-Operating-Cash-Flow | 29.53 | |||||
EV-to-EBIT | 8.7 | |||||
EV-to-Forward-EBIT | 7.98 | |||||
EV-to-EBITDA | 8.7 | |||||
EV-to-Forward-EBITDA | 6.41 | |||||
EV-to-Revenue | 0.28 | |||||
EV-to-Forward-Revenue | 0.26 | |||||
EV-to-FCF | -97.52 | |||||
Price-to-Projected-FCF | 1.04 | |||||
Price-to-DCF (Earnings Based) | 0.79 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Graham-Number | 0.97 | |||||
Price-to-Net-Current-Asset-Value | 3.5 | |||||
Earnings Yield (Greenblatt) % | 11.49 | |||||
FCF Yield % | -1.22 | |||||
Forward Rate of Return (Yacktman) % | 6.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Pharmaceuticals Holding Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 33,914.023 | ||
EPS (TTM) (€) | 0.133 | ||
Beta | -0.06 | ||
Volatility % | 21.55 | ||
14-Day RSI | 50.86 | ||
14-Day ATR (€) | 0.025025 | ||
20-Day SMA (€) | 1.393 | ||
12-1 Month Momentum % | -18.02 | ||
52-Week Range (€) | 1.18 - 1.79 | ||
Shares Outstanding (Mil) | 3,703.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Pharmaceuticals Holding Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Pharmaceuticals Holding Co Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Shanghai Pharmaceuticals Holding Co Ltd Frequently Asked Questions
What is Shanghai Pharmaceuticals Holding Co Ltd(STU:S1R)'s stock price today?
When is next earnings date of Shanghai Pharmaceuticals Holding Co Ltd(STU:S1R)?
Does Shanghai Pharmaceuticals Holding Co Ltd(STU:S1R) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |